Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.
about
MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5.Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57.The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies.miR-134: A Human Cancer Suppressor?Disease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.Matrix metalloproteinases: their functional role in lung cancer.Long non-coding RNA LOC100129148 functions as an oncogene in human nasopharyngeal carcinoma by targeting miR-539-5p.Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.Structure Identification and In Vitro Anticancer Activity of Lathyrol-3-phenylacetate-5,15-diacetate.The Exosome Total Isolation Chip.The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2.Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI.HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway.LincRNA FEZF1-AS1 contributes to the proliferation of LAD cells by silencing p57 expression.DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells.Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2
P2860
Q37482545-6255BF8A-16A8-4CAF-8286-1C7967F33B97Q37501589-29FD4A85-7457-4AD4-93AF-BC73E551A63BQ37501595-9946828E-4F0A-42D2-9327-2A9824397D15Q37530948-FED236C2-22A1-4410-BD6F-A52AC0DB3BB0Q37588369-2EAECFC3-219C-47BE-A1FD-5C8E4F2AA390Q37688454-DDD45EBB-D2E0-4CED-BB62-6DBAFC3D2308Q37718061-4EB3C0B4-4501-4597-A72F-4D914EC14BA7Q38430756-0F974D3F-A039-4F5E-8107-7FBC49816877Q38814178-930BB639-75F3-4877-AFB9-681BA9739ADCQ39306735-DA9C137E-758F-4769-9C24-388CADD0D536Q39388493-8D9F5380-EEF0-4624-AB92-1C7C007F2672Q41910784-FE8092D9-1DD3-4AD4-BC2A-5B44FF520C9EQ42288460-2B59A83B-755C-4178-A1DC-AC751CFB187CQ42370600-D59BCAB5-DE36-4011-8942-E1DD5B7408F8Q45216227-182E70B9-4E7D-40C7-8F7D-E9A492C0D182Q46316359-F8365DE4-37B2-42A5-BFC2-305BDF95D48FQ46672367-A044F460-C22E-4C9F-9ADE-F05840FB3DFEQ46675216-4A2EC79A-8FE0-4430-85D1-F0BF76E43A80Q47098762-A786FF53-E2F4-4E60-BB0C-E06A0182306EQ47111787-D308E47C-1AD9-4C2E-80DC-4D7C5841C7C0Q47120277-7BB0EF21-42A2-4D79-A1F0-D24D48AD4ABAQ47830977-0A5FBD19-45BF-4CCD-9E99-309BD622F86DQ49164115-2601B4CD-29C6-451F-9E66-11B3FD03C76DQ54988438-EFE9F1EB-2954-4088-BDB8-F066BADB21F0Q55153270-79E4C295-0BA8-4BB2-8B42-C3F002D61581Q58757340-60AD57D8-88F6-423B-B26A-F1485EB77080
P2860
Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hsa-miR-134 suppresses non-sma ...... ough down-regulation of CCND1.
@en
Hsa-miR-134 suppresses non-small cell lung cancer
@nl
type
label
Hsa-miR-134 suppresses non-sma ...... ough down-regulation of CCND1.
@en
Hsa-miR-134 suppresses non-small cell lung cancer
@nl
prefLabel
Hsa-miR-134 suppresses non-sma ...... ough down-regulation of CCND1.
@en
Hsa-miR-134 suppresses non-small cell lung cancer
@nl
P2093
P2860
P356
P1433
P1476
Hsa-miR-134 suppresses non-sma ...... ough down-regulation of CCND1.
@en
P2093
Cheng-Cao Sun
Shu-Jun Li
P2860
P304
35960-35978
P356
10.18632/ONCOTARGET.8482
P407
P577
2016-03-30T00:00:00Z